))
#34 - Cary Claiborne, CEO of Adial Pharmaceuticals
Manage episode 401017468 series 3478706
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.
What you'll get out of this episode:
- Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.
- Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.
- The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.
- A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.
- Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/
Company LinkedIn: https://www.linkedin.com/company/adialpharma/
Website: https://www.adial.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
43 episodes
Share
